AMC III successfully realised its investment in Biovendor

Accession Mezzanine Capital III L.P., advised by Mezzanine Management, realised its investment in Czech in-vitro diagnostics and life sciences business BioVendor after a three and a half year hold.

AMC III first invested in BioVendor in 2014, providing a EUR 8 million warranted loan to support BioVendor’s expansion both organically and via acquisitions. During its investment, BioVendor completed eight acquisitions in Germany, Austria, the UK, the Czech Republic and Slovakia and invested heavily in new product development.

The loan was repaid in December 2016 less than three-years after the initial investment. AMC III retained a minority stake through its equity warrants which were realised alongside a majority share sale to a Czech private investment group in mid 2017.